UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049701
Receipt No. R000051498
Scientific Title Development of a new predictive model for inpatient's fall using public ADL scale in Japan (Bedriddennes rank and cognitrefanetion score);single-center retrospective cohort study of fall injury
Date of disclosure of the study information 2022/12/10
Last modified on 2022/12/06 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Development of a prediction model for fall injury in an acute care hospital in Japan
Acronym Development of a prediction model for fall injury in an acute care hospital in Japan
Scientific Title Development of a new predictive model for inpatient's fall using public ADL scale in Japan (Bedriddennes rank and cognitrefanetion score);single-center retrospective cohort study of fall injury
Scientific Title:Acronym Development of a prediction model for fall injury in an acute care hospital in Japan: single-center retrospective cohort study;single-center retrospective cohort study
Region
Japan

Condition
Condition Fall injury
Classification by specialty
Medicine in general Geriatrics Nursing
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Developing a model to predict fall injury for all hospitalized patients
Basic objectives2 Others
Basic objectives -Others Exploing factors related to fall injuy
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Fall Injury during hospitalization
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria All patients 20 years of age or older admitted to the study facility during the study period
Key exclusion criteria Patients who refused an agreement
Target sample size 17062

Research contact person
Name of lead principal investigator
1st name Masaki
Middle name
Last name Tago
Organization Saga University Hospital, Japan
Division name Department of General Medicine
Zip code 8498501
Address 5-1-1 Nabeshima, Saga 849-8501, Japan
TEL 0952343238
Email tagomas@cc.saga-u.ac.jp

Public contact
Name of contact person
1st name Masaki
Middle name
Last name Tago
Organization Saga University Hospital, Japan
Division name Department of General Medicine
Zip code 8498501
Address 5-1-1 Nabeshima, Saga 849-8501, Japan
TEL 0952343238
Homepage URL
Email tagomas@cc.saga-u.ac.jp

Sponsor
Institute Department of General Medicine, Saga University Hospital
Institute
Department

Funding Source
Organization Japan Society for the promotion of science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Yuai-Kai Foundation and Oda Hospital, Saga, Japan
Address 4306 Takatsuhara, Kashima 849-1311, Saga
Tel 0954633275
Email renkei@yuai-hc.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 12 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 17062
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 11 Month 24 Day
Date of IRB
2022 Year 11 Month 24 Day
Anticipated trial start date
2022 Year 11 Month 24 Day
Last follow-up date
2022 Year 11 Month 30 Day
Date of closure to data entry
2022 Year 11 Month 30 Day
Date trial data considered complete
2022 Year 11 Month 30 Day
Date analysis concluded
2022 Year 12 Month 06 Day

Other
Other related information For all inpatients, age, sex, department of admission (internal medicine, neurosurgery, others), emergency admission (presence or absence), ambulance transfer (presence or absence), referral letter (presence or absence), history of fall (presence or absence), hypnotic medication (presence or absence), visual impairment (presence or absence), Parkinson's syndrome (presence or absence), sequelae of stroke (presence or absence), basic ADLs (eating, swallowing, excretion, sitting, standing, transferring, moving, bathing, taking prescription drug) (independent, requiring assistance), bed-riddenness rank (normal, J, A, B, C), cognition score (normal, 1, 2, 3, 4, M), rehabilitation during hospitalization (presence or absence), surgery during hospitalization (presence or absence), fall during hospitalization (presence or absence), for the patients who fell degree of injury due to fall (no injury, LV1, 2, 3), date of admission and discharge

Management information
Registered date
2022 Year 12 Month 06 Day
Last modified on
2022 Year 12 Month 06 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051498